Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window
- PMID: 20567854
- DOI: 10.1007/s00467-010-1574-2
Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window
Abstract
Both vitamin D deficiency and vitamin D toxicity are associated with cardiovascular complications in chronic kidney disease (CKD). Clinical and experiment data indicate that the association of vitamin D levels with cardiovascular disease is best illustrated as a biphasic, or U-shaped, curve. Children and adolescents with CKD need vitamin D due to the demands of a growing skeleton, to prevent renal rickets. However, this therapy carries the risk of severe side effects and chronic toxicity. Observational studies show that vitamin D deficiency and toxicity are frequently present in patients with CKD. In view of the importance of cardiovascular complications for the long-term survival of young patients, these findings demand a judicious use of vitamin D preparations. In clinical practice, the therapeutic window is rather small, presenting a therapeutic challenge to avoid both vitamin D deficiency and toxicity.
Similar articles
-
Vitamin D therapy in chronic kidney disease and end stage renal disease.Clin J Am Soc Nephrol. 2012 Feb;7(2):358-65. doi: 10.2215/CJN.04040411. Epub 2011 Dec 22. Clin J Am Soc Nephrol. 2012. PMID: 22193236 Free PMC article. Review.
-
Vitamin D and the cardiovascular system.Clin J Am Soc Nephrol. 2009 Sep;4(9):1515-22. doi: 10.2215/CJN.02260409. Epub 2009 Aug 20. Clin J Am Soc Nephrol. 2009. PMID: 19696220 Review.
-
Does vitamin D protect against cardiovascular disease?J Cardiovasc Transl Res. 2009 Sep;2(3):245-50. doi: 10.1007/s12265-009-9111-z. Epub 2009 Jul 17. J Cardiovasc Transl Res. 2009. PMID: 20560014 Review.
-
Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease.Clin J Am Soc Nephrol. 2009 Sep;4(9):1529-39. doi: 10.2215/CJN.02140309. Epub 2009 Aug 6. Clin J Am Soc Nephrol. 2009. PMID: 19661219 Review.
-
Chronic kidney disease and vitamin D: how much is adequate?Kidney Int. 2009 Nov;76(9):931-3. doi: 10.1038/ki.2009.312. Kidney Int. 2009. PMID: 19829313
Cited by
-
Neurologic Complications of Chronic Kidney Disease.Curr Neurol Neurosci Rep. 2015 Aug;15(8):50. doi: 10.1007/s11910-015-0577-6. Curr Neurol Neurosci Rep. 2015. PMID: 26081561 Review.
-
Metabolic Advantage of 25(OH)D3 versus 1,25(OH)2D3 Supplementation in Infantile Nephropathic Cystinosis-Associated Adipose Tissue Browning and Muscle Wasting.Cells. 2022 Oct 17;11(20):3264. doi: 10.3390/cells11203264. Cells. 2022. PMID: 36291130 Free PMC article.
-
1,25(OH)2D3 alters growth plate maturation and bone architecture in young rats with normal renal function.PLoS One. 2011;6(6):e20772. doi: 10.1371/journal.pone.0020772. Epub 2011 Jun 13. PLoS One. 2011. PMID: 21695192 Free PMC article.
-
Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial.Obstet Gynecol. 2017 Jan;129(1):121-129. doi: 10.1097/AOG.0000000000001774. Obstet Gynecol. 2017. PMID: 27926633 Free PMC article. Clinical Trial.
-
Effect of dietary vitamin D and calcium on the growth of androgen-insensitive human prostate tumor in a murine model.Anticancer Res. 2012 Mar;32(3):727-31. Anticancer Res. 2012. PMID: 22399584 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical